MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults
Imported from official source
As with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review.
This version
- Version
- 1 of 1
- Recorded
- October 23, 2026 16:00
- Change
- Initial
- Content hash
78c08271a73e07c46f15d21e2799206e- All versions
- Revision history